Independent Advisor Alliance’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Independent Advisor Alliance's NVO Position: Q1 2026 in Review
Independent Advisor Alliance reduced its Novo Nordisk (NVO) stake by 10% in Q1 2026, selling an estimated $189K and leaving 34,808 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #713.
Independent Advisor Alliance first reported a position in NVO in Q4 2018 and has held it in 30 quarters since. The position peaked at $10M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Independent Advisor Alliance held 34,808 shares of Novo Nordisk worth $1.28M as of Q1 2026.
- Independent Advisor Alliance sold 3,981 Novo Nordisk shares in Q1 2026, an estimated $189K.
- Novo Nordisk made up 0.01% of Independent Advisor Alliance's portfolio in Q1 2026, its #713 holding.
- Independent Advisor Alliance first reported a position in Novo Nordisk in Q4 2018 and has held it in 30 quarters since.
- Independent Advisor Alliance's Novo Nordisk position peaked at $10M in Q2 2024.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Independent Advisor Alliance's 13F filing for Q1 2026, filed 12 May 2026.